| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology platform company providing enterprise-focused Immersive Technology, Spatial Computing and Artificial Intelligence ("AI") driven software and services, today announced that is was awarded a prestigious, Small Business Technology Transfer (STTR) grant from the National Institute of Nursing Research at the National Institutes of Health (NIH), in partnership with Yale School of Medicine (YSM), Drexel University, and New Jersey Institute of Technology (NJIT).
The mid-six figure dollar project, "Life at 100.4: An Immersive Social Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers," will develop and evaluate an immersive VR-based program designed to improve patient understanding and management of febrile neutropenia during cancer treatment.
Nearly 90,000 adolescents and young adults are diagnosed with cancer each year in the United States. Febrile neutropenia, a dangerous complication of treatment, can be life-threatening if not addressed quickly. This initiative leverages cutting-edge virtual reality technology to provide engaging, evidence-based education for patients and caregivers, helping them recognize symptoms early and navigate the healthcare system effectively.
Dr. Asher Marks, Yale School of Medicine (Principal Investigator), commented: "Adolescents and young adults with cancer face unique challenges, and delays in care can have devastating consequences. By using immersive VR experiences, we aim to bridge knowledge gaps, improve health literacy, and ultimately save lives. This project represents a critical step in using digital innovation to empower patients and caregivers."
DJ Smith, Chief Creative Officer, The Glimpse Group (Co-Investigator), commented: "At Glimpse, we've seen the transformative potential of VR across industries, and healthcare is one of the most impactful areas. Partnering with YSM, Drexel, and NJIT allows us to bring together world-class medical expertise, immersive technology, and design innovation to tackle one of the most urgent problems in oncology care."
Posted In: VRAR
